Page 16 - காரணிகள் அந்த இருக்கலாம் செயல்விளைவு உண்டுபண்ணு எதிர்கால News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from காரணிகள் அந்த இருக்கலாம் செயல்விளைவு உண்டுபண்ணு எதிர்கால. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In காரணிகள் அந்த இருக்கலாம் செயல்விளைவு உண்டுபண்ணு எதிர்கால Today - Breaking & Trending Today

BioNTech SE: Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY in the EU to Adolescents

BioNTech SE: Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY in the EU to Adolescents
1
(Nasdaq: BNTX) today announced they have submitted a variation to the Conditional Marketing Authorization (CMA) in the European Union (EU) to the European Medicines Agency (EMA) for the Pfizer-BioNTech vaccine COMIRNATY
(BNT162b2) to request an extension of the indication for use in adolescents 12 to 15 years of age. If EMA approves the variation, the amended CMA will be valid in all 27 member states of the EU. The companies have already submitted a similar request to the U.S. Food and Drug Administration (FDA) for the Emergency Use Authorization (EUA) and plan to request additional amendments with other regulatory authorities worldwide. ....

United States , United Kingdom , Sylke Maas , Andy Widger , Chuck Triano , Fosun Pharma , European Commission , Drug Administration , Bayer Animal Health , Exchange Commission , European Union , European Medicines Agency , Roche Group , Conditional Marketing Authorization , Emergency Use Authorization , Marketing Authorization Holder , Product Characteristics , Package Leaflet , Breakthroughs That Change Patient , Pfizer News , Biologics License Application , Annual Report , Looking Information , Factors That May Affect Future , New Technologies , Private Securities Litigation Reform Act ,

Pfizer : Acquires Amplyx Pharmaceuticals

Deal expands anti-infectives pipeline with addition of novel antifungal Phase 2 candidate, Fosmanogepix

Opportunity to advance Pfizer’s expertise and deep heritage in infectious disease
. | April 28, 2021 ....

Angela Lukin , Arix Bioscience , Amplyx Pharmaceuticals Inc , National Prevalence Of Fungal Diseases , World Health Organization , Drug Administration , Amplyx Pharmaceuticals , Global Health Data Exchange , Institute For Health Metrics , Exchange Commission , University Of Washington , Pfizer Inc , Enterprise Associates , Global President , Adage Capital Management , Biomed Ventures , Lundbeckfonden Ventures , New Enterprise Associates , Pappas Capital , Rivervest Venture Partners , Breakthroughs That Change Patient , Pfizer News , Annual Report , Looking Information , Factors That May Affect Future , Multi National Prevalence ,

Investegate |Arix Bioscience PLC Announcements | Arix Bioscience PLC: Amplyx Pharmaceuticals acquired by Pfizer

About Arix Bioscience plc
Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting-edge advances in life sciences.

We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. www.arixbioscience.com

Pfizer Acquires Amplyx Pharmaceuticals
Opportunity to advance Pfizer s expertise and deep heritage in infectious disease
NEW YORK Pfizer Inc. (NYSE: PFE) announced today that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx s lead compound, Fosmanogepix (APX001), is a nove ....

City Of , United Kingdom , Supriya Mathur , Aboutarix Bioscience , Charlotte Parry , Shabnam Bashir , Eamonn Nolan , Arix Bioscience , Angela Lukin , Mary Clark , Chuck Triano , Amplyx Pharmaceuticals Inc , National Prevalence Of Fungal Diseases , Amplyx Pharmaceuticals , Global Health Data Exchange , Institute For Health Metrics , University Of Washington , Pfizer Inc , York Pfizer Inc , Pfizer Acquires Amplyx Pharmaceuticals , Drug Administration , World Health Organization , Exchange Commission , Strategic Communications , Enterprise Associates , Global President ,

Pfizer Acquires Amplyx Pharmaceuticals

Pfizer Acquires Amplyx Pharmaceuticals
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

Angela Lukin , Eamonn Nolan , Chuck Triano , Arix Bioscience , Amplyx Pharmaceuticals Inc , National Prevalence Of Fungal Diseases , World Health Organization , Drug Administration , Amplyx Pharmaceuticals , Global Health Data Exchange , Institute For Health Metrics , Exchange Commission , University Of Washington , Pfizer Inc , Enterprise Associates , Global President , Adage Capital Management , Biomed Ventures , Lundbeckfonden Ventures , New Enterprise Associates , Pappas Capital , Rivervest Venture Partners , Breakthroughs That Change Patient Lives , Pfizer News , Annual Report , Looking Information ,

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Andy Widger , Albert Bourla , Relationssylke Maas , Relationsjasmina Alatovic , Sean Marett , Relationschuck Triano , Fosun Pharma , European Commission , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , Roche Group , European Medicines Agency , Wall Street , Advanced Purchase Agreement , Chief Executive Officer , Chief Business , Chief Commercial Officer , Product Characteristics , Package Leaflet , Breakthroughs That Change Patient , Pfizer News , Biologics License Application , Annual Report , Looking Information ,